EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS184-07869 
Organism
Homo sapiens 
Tissue/cell
T47D 
Coordinate
chr12:65995980-65997630 
TF binding sites/motifs
Number: 21             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr12:65997596-65997614GGAGGAAGGGAGGGAAGG+6.03
EWSR1-FLI1MA0149.1chr12:65997612-65997630GGAGGAAGGGAAAGAAGG+6.03
EWSR1-FLI1MA0149.1chr12:65997608-65997626GGAAGGAGGAAGGGAAAG+6.16
EWSR1-FLI1MA0149.1chr12:65997595-65997613GGGAGGAAGGGAGGGAAG+6.27
EWSR1-FLI1MA0149.1chr12:65997575-65997593AGAAGGAAGGGAGGGAGG+6.71
EWSR1-FLI1MA0149.1chr12:65997591-65997609GGGAGGGAGGAAGGGAGG+6.88
EWSR1-FLI1MA0149.1chr12:65997579-65997597GGAAGGGAGGGAGGGAGG+7.08
EWSR1-FLI1MA0149.1chr12:65997587-65997605GGGAGGGAGGGAGGAAGG+7.28
Foxd3MA0041.1chr12:65996907-65996919AAATGTTTGTTT+6.27
RELMA0101.1chr12:65997491-65997501GGGGATTTCC+6.02
ZNF263MA0528.1chr12:65996992-65997013CCCTTCCCTTCCTGCTCCACC-6.52
ZNF263MA0528.1chr12:65997573-65997594AAAGAAGGAAGGGAGGGAGGG+6.65
ZNF263MA0528.1chr12:65997597-65997618GAGGAAGGGAGGGAAGGAGGA+6.89
ZNF263MA0528.1chr12:65996989-65997010CCACCCTTCCCTTCCTGCTCC-7.07
ZNF263MA0528.1chr12:65997581-65997602AAGGGAGGGAGGGAGGGAGGA+7.14
ZNF263MA0528.1chr12:65997585-65997606GAGGGAGGGAGGGAGGAAGGG+7.19
ZNF263MA0528.1chr12:65997596-65997617GGAGGAAGGGAGGGAAGGAGG+7.33
ZNF263MA0528.1chr12:65997576-65997597GAAGGAAGGGAGGGAGGGAGG+7.38
ZNF263MA0528.1chr12:65997589-65997610GAGGGAGGGAGGAAGGGAGGG+7.5
ZNF263MA0528.1chr12:65997593-65997614GAGGGAGGAAGGGAGGGAAGG+7.88
ZNF263MA0528.1chr12:65997609-65997630GAAGGAGGAAGGGAAAGAAGG+8.52
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_02751chr12:65995784-66000261Astrocytes
SE_36258chr12:65995022-66000789HMEC
SE_45565chr12:65994741-66010962Osteoblasts
SE_55837chr12:65994046-66009639u87
SE_67447chr12:65994046-66009639u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr126599721265997538
Enhancer Sequence
ATGCCATAGG TATTTCAGTA ATATAGACTG TTCAATAAAT TATTGGGTAG TTATTAGAAC 60
GAGGTAAATT TGACTTAACA TCTTAATTTG ACTTAGGCAT CTTCCTGGAA CCTTCTTGCT 120
CTGAGGTTTG GATGAAAAAC ACTTTGGATA TCACCGTGAG ACTTGCTACT TCCGATTCAT 180
TGTCTAGTAT TCTCCTTGGC AGCTTTGCAA AACAAATCTT GGAAAGCTCC TAGAGAAAGC 240
CATTCTTTTT AGAAAACTTG GAGTCTTTTG AATTCACGCT GGATGACAAT GACAGTGAAT 300
GAAAGTGTTT GTCCTGTTTG TATATTTGCC TGCTGCTTTG CTCATTCACT CGCTATTCAT 360
TTTTTCCAAT GGATTATTTA TTTATTCAAT TTTCAAAACT TAGCAAATAT CCTAGATTTC 420
AAAGTATCCT TGTACCCTAT GGTTATGGGA ATGTGTCAGC CAAACTCTAG GTGGCGCTCC 480
ACATCGAATT TAGGAGGCAG GGGAAGGAGT GTGGCAGTGG AGCTCTCAGG ATGGCGTCAG 540
AACCACAGAA CACCCAGGCT GATCCCGAGA GCTTCCCGTG TGGGGGCGGA GGGTGGGGCA 600
GAGCAGGATG TGTGCTTGGG TTTCACTTGG AAAAAACATA CATCATATTG CAATATAATT 660
TACTTTGAGA TTTCAATTTG GAAAATGGCA TGGAAATAAT CCAGCTTGAA CATCGTCCTC 720
CTCACCTCCT GGACTAGGGC GAGGGCCCCT TATATTTCTT CATGGCAATT GTGTCACAGT 780
TGTAAGTATT AAAGTATTTG CTTAATTATT TGTTTGATAT CCGCCCACTT TGGACTGTAA 840
ATTTCACAAG GCAAGGACCT GGCTGCATGG CTCATAGCTA TTTGCCTGCT GTCTATCACA 900
ACACCTAGCA AGTGACAGAC GGTCAATAAA TGTTTGTTTT GTTTGCTTAT TTGGCTGCTG 960
CTCCATTCAT TTGCTTCACT GGGTTATTCA TTTTTTCATT CCTTCGTCTC CACCCTTCCC 1020
TTCCTGCTCC ACCCTACCCT TATCTTCCAT CCCCCACTCC AACTCTCCCA GTCCTCCCAG 1080
CCCTCCCATC TACCCCATTC CCCACCCAGT CCCACCCTCA TTTATCATAA GTCTTAAAAG 1140
TTAAGAAACC TAAGGGGGCT GTAGTGGGGT GGGGCAGAAA CTAAATGTAT GAAAGCAATC 1200
TTTAAATAGT CGGATTCTCA AAATCCGGAG AAAGAGTATT AAAAGGTAAG AAAGCAACAG 1260
TTTTGCCAAT GCAAAAGGGA AAGTGTGGCC CCCTCAGCGG TCATTTCCCC ATGCACTATG 1320
GCTTTCCTAA GCAGGTGCTG CACCTCCTGG GTTTTGGCAA CTGGATGCAG AAGACCGGCA 1380
GAACTCTTTC CTCTGAATGG TCTGGACTGG GGACAATTGG CTGGAATCAC AAGTGGCTTC 1440
TTTGCTCACT CTAGCGGTAC TTCAGCTTTC ATAAACAGCC GGTTCCTGGA GCTGTAAGGT 1500
TCCAGCACAT CGGGGATTTC CCTTTGTTAG ATCCTGACCC GCAGAGCTGT GTCCCAAGCC 1560
AAAACTGTTG TGTTCACCTC TTAAAAGGCT TTCAAAGAAG GAAGGGAGGG AGGGAGGGAG 1620
GAAGGGAGGG AAGGAGGAAG GGAAAGAAGG 1650